Showing 5331-5340 of 5909 results for "".
- Acuity Eyecare Group Announces Rebranding and New Corporate Namehttps://modernod.com/news/acuity-eyecare-group-announces-rebranding-and-new-corporate-name/2477131/Acuity Eyecare Group, which operates leading eyecare groups across the U.S. and has backing by private equity group Riata Capital, is announcing a new name, AEG Vision, along with other corporate updates, according to a
- Mark McGrath to Headline Celebration at Optometry’s Meeting 2020https://modernod.com/news/mark-mcgrath-to-headline-celebration-at-optometrys-meeting-2020/2477126/The American Optometric Association has announced that it is celebrating the decade of the 90s at its annual Optometry’s Meeting, June 24-28, in National Harbor, Maryland/Washington, D.C. “Mark McGrath’s ’90s Experience” will headline the closing Celebration o
- Air Pollution Linked to Higher Glaucoma Riskhttps://modernod.com/news/air-pollution-linked-to-higher-glaucoma-risk/2477124/People in neighborhoods with higher amounts of fine particulate matter pollution were at least 6% more likely to report having glaucoma than those in the least-polluted areas, according to the findings published in Investigative Ophthalmology & Visual Science. “We have found yet
- GN Corporation: Vision Restored with Corneal Cell Transplant Using a Nano Sheet Techniquehttps://modernod.com/news/gn-corporation-vision-restored-with-corneal-cell-transplant-using-a-nano-sheet-technique/2477121/A novel cell transplantation method to treat corneal endothelial diseases such as bullous keratopathy using a nano-composite gel sheet developed by Japanese scientists was granted Indian patent to GN Corporation (GNC), Japan, according to a company news release. This method was earlier granted a
- Iveric bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapyhttps://modernod.com/news/iveric-bio-appoints-guangping-gao-phd-internationally-recognized-gene-therapy-pioneer-as-chief-strategist-gene-therapy/2477122/Iveric bio announced the appointment of Guangping Gao, PhD, as Chief Strategist, Gene Therapy. Dr. Gao brings more than 30 years of scientific research experience in gene-based treatments. As one of the world’s leading gene therapy experts, Dr. Gao’s highly distinguished career includes major con
- Teva, Drugmakers in Talks With U.S. to End Generics Probeshttps://modernod.com/news/teva-drugmakers-in-talks-with-u-s-to-end-generics-probes/2477123/Teva Pharmaceutical Industries and other generic drugmakers have held talks with the U.S. Justice Department in the past 6 months about resolving a long-running criminal antitrust probe of alleged price-fixing by the companies, according to people familiar with the matter, as
- Alcon to Hold Second Annual Alcon Retina Fellows Institutehttps://modernod.com/news/alcon-to-hold-second-annual-alcon-retina-fellows-institute/2477120/Alcon announced it will host future ophthalmology leaders for the second annual Alcon Retina Fellows Institute, an educational experience where first year retina fellows gain hands-on surgical training and mentorship from some of the leading ophthalmologists in the field, according to a company n
- Clearwave Announces Interface with Modernizing Medicinehttps://modernod.com/news/clearwave-announces-interface-with-modernizing-medicine/2477113/Clearwave, a provider of patient check-in solutions via mobile, kiosk and desktop, announced a new interface with award-winning health IT company, Modernizing Medicine. This announcement comes as Modernizing Medicine’s 2019 user conference, MOMENTUM, kicks off in Orlando, Florida. The Clea
- ProtoKinetix AAGP Dry Eye Therapy Program Launchedhttps://modernod.com/news/protokinetix-aagp-dry-eye-therapy-program-launched/2477115/ProtoKinetix announces the initiation of a program testing AAGP to develop a potential therapy to treat dry eye disease (DED). AAGP has demonstrated anti-inflammatory and cytoprotective properties, and also exhibits pharmaceutical properties beneficial for topical formulations, according to a com
- Johnson & Johnson Vision Announces Availability of Acuvue Oasys with Transitions Light Intelligent Technology in the UKhttps://modernod.com/news/johnson-johnson-vision-announces-availability-of-acuvue-oasys-with-transitions-light-intelligent-technology-in-the-uk/2477102/Johnson & Johnson Vision announced the national availability of Acuvue Oasys with Transitions Light Intelligent Technology in the UK. The first-of-its-kind photochromic contact lens offers superior visual performance indoor and outdoor, day and night, according to a company news release.